News & Views

Council Commentary

First Multipurpose Gel Designed to Prevent HIV, HSV, and HPV Simultaneously in Women and Men Advances in Clinical Trials

NEW YORK, NY (June 21, 2018) – A new Phase I study of the Population Council’s multipurpose prevention technology (MPT) gel PC-1005, launching this week, will examine the safety of the gel when used rectally by both men and women. If proven effective, PC-1005 gel would be the first product to prevent three incurable sexually transmitted infections (STIs)—HIV, herpes simplex virus (HSV), and human papillomavirus (HPV)—when used either vaginally or rectally. 

Read more

Council Commentary

Making the Dream to End HIV a Reality by Empowering Adolescent Girls and Young Women: Emerging lessons from the DREAMS partnership

The Center for Global Development and the Population Council co-hosted a high-level discussion on emerging insights from the DREAMS initiative, an ambitious partnership to reduce HIV infections among adolescent girls and young women in 10 sub-Saharan African countries.  Supported by the Bill and Melinda Gates Foundation, Girl Effect, and the President’s Emergency Plan for AIDS Relief (PEPFAR) through Project SOAR, the Population Council leads the DREAMS implementation science and capacity building portfolios.

Read more

Media Coverage

CTI Exchange: Contraception Technology Innovation is Everyone’s Business, Writes Julia Bunting and Laneta Dorflinger

In a blog post for FHI 360’s Contraceptive Technology Innovation Exchange, Julia Bunting, President of the Population Council, and Laneta Dorflinger, Distinguished Scientist and Director for Contraceptive Technology, outline what needs to be done to increase access to the broadest choice of quality, affordable, and acceptable contraceptives.

Read more

Media Coverage

POZ: FDA Approval of PrEP for Adolescents is a Great Start, Writes Council Expert

Council researcher Nanlesta Pilgrim writes about the U.S. Food and Drug Administration (FDA)'s recent decision to expand the approval of Truvada as pre-exposure prophylaxis (PrEP) against HIV for use in at-risk adolescents and the continued need to improve services for adolescents, in the U.S. and around the world. 

Read more